BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Sep 4, 2026, 4:00 PM EDT
2.000
0.00 (-0.01%)
After-hours: Sep 4, 2026, 7:58 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $15.09 million as of September 4, 2026. Its market cap has increased by 19.72% in one year.
Market Cap
15.09M
Enterprise Value
6.38M
1-Year Change
19.72%
Ranking
Category
Stock Price
$2.00
ChartMarket Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $15.09M, a decrease of -70.99%. That is a compound annual growth rate of -18.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 15.10M | 73.56% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 16.46M |
| BioCardia | 16.35M |
| Citius Pharmaceuticals | 16.13M |
| Vyome Holdings | 15.58M |
| Passage Bio | 14.96M |
| Lisata Therapeutics | 14.87M |
| CalciMedica | 14.82M |
| Pluri | 14.67M |